Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 2011

View Archived Issues

Abciximab combined with heparin may be useful to treat stroke

Omeros identifies compounds that interact with GPCRs linked to metabolic and psychotic disorders

Solvay's SLV-338 alleviates symptoms of pulmonary hypertension in vivo

Novel MEK 1 inhibitors synthesized at Novartis

Athersys reports interim data from ongoing phase I MultiStem study

Preliminary phase III data presented at ASCO on bosutinib versus imatinib in Ph+ CML

Proactivator polypeptide described as new biomarker in prostate cancer

New data disclosed on duloxetine in chronic depression, MDD and GAD

Gilead presents new voltage-gated Na(V)1.5 sodium channel blockers

Novadex Pharmaceuticals discloses novel renin inhibitors

Grindeks claims new cognition-enhancing piracetam derivative enantiomer

New ghrelin receptor antagonists and/or inverse agonists synthesized

Novel 9-aminoacridine derivatives for cancer presented

Immunovaccine's phase I DPX-0907 trial meets primary objective

Asimadoline receives FDA fast track status for diarrhea-predominant irritable bowel syndrome

Ono and Daninippon Sumitomo to codevelop limaprost for carpal tunnel syndrome

Recruitment begins in phase Ib Ampion trial in osteoarthritis of the knee

Phase III data reported on CVT-E002 for acute respiratory illness in chronic lymphocytic leukemia

Aastrom's RESTORE-CLI trial meets primary safety and efficacy endpoints

Week 56 data consistent with earlier results in phase III lomitapide trial in HoFH

Kyowa Hakko Kirin and Valeant terminate North American licensing agreement for KW-6002

Bristol-Myers Squibb and Roche enter agreement to evaluate ipilimumab/vemurafenib combination

AVEO and Centocor Ortho Biotech enter license agreement for antibodies targeting MSP receptor

Lpath reports encouraging preclinical data on Lpathomab

GSK and Theravance provide results from two pivotal phase III Relovair trials in COPD

FDA finds no evidence of increased risk of cancer in safety review of ARBs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...